Pneumonia Qingjie Granule

Pneumonia Qingjie Granule is a Traditional Chinese Medicine (TCM) herbal formulation developed by Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine. It is specifically designed for the treatment of non-severe community-acquired pneumonia (CAP), particularly in patients presenting with the TCM syndrome of phlegm-heat obstructing the lung. The formulation is administered orally as a granule and is typically used as an adjunctive therapy alongside routine medical treatment. Clinical evaluation of the drug focuses on its ability to improve clinical outcomes such as the Clinical Pulmonary Infection Score (CPIS), reduce inflammatory markers (including C-reactive protein and procalcitonin), and alleviate TCM-specific symptoms. As a multi-herb TCM product, its therapeutic effects are attributed to broad anti-inflammatory and antimicrobial properties inherent in its botanical components.

Other names

Pneumonia Qingjie GranuleFeiyan Qingjie KeliPneumonia Qingjie Granules